Bibliographic Citation
| - Berchel Mathieu, Davies L., Mottais A., Ghanem R., Fautrel A., Gill D., Hyde S., Lehn P., Lehn J.-M., Lemiègre L., Benvegnu T., Jaffrès P.-A., Pitard B.. Aerosol-mediated non-viral lung gene therapy: The potential of aminoglycoside-based cationic liposomes. Pharmaceutics, MDPI, 2022, 14 (1), pp.25. ⟨10.3390/pharmaceutics14010025⟩
- Berchel Mathieu, Davies L., Mottais A., Ghanem R., Fautrel A., Gill D., Hyde S., Lehn P., Lehn J.-M., Lemiègre L., Benvegnu T., Jaffrès Paul-Alain, Pitard B.. Aerosol-mediated non-viral lung gene therapy: The potential of aminoglycoside-based cationic liposomes. Pharmaceutics, MDPI, 2022, 14 (1), pp.25. ⟨10.3390/pharmaceutics14010025⟩
- Berchel Mathieu, Davies L., Mottais A., Ghanem R., Fautrel A., Gill D., Hyde S., Lehn P., Lehn J.-M., Lemiègre Loïc, Benvegnu T., Jaffres Paul-Alain, Pitard B. . Aerosol-mediated non-viral lung gene therapy: The potential of aminoglycoside-based cationic liposomes . Pharmaceutics, 2022, 14 (1), pp.25 . ⟨10.3390/pharmaceutics14010025⟩
- Berchel Mathieu, Davies L., Mottais A., Ghanem R., Fautrel A., Gill D., Hyde S., Lehn P., Lehn J.-M., Lemiègre Loïc, Benvegnu T., Jaffres Paul-Alain, Pitard B.. Aerosol-mediated non-viral lung gene therapy: The potential of aminoglycoside-based cationic liposomes. Pharmaceutics, 2022, 14 (1), pp.25. ⟨10.3390/pharmaceutics14010025⟩
|